Corporate Taxes, Inversion, Pfizer

Texas Federal District Court Invalidates IRS Regulations Limiting Inversion Transactions

A&O Shearman on 10/24/2017

On September 29, 2017, the United States District Court for the Western District of Texas granted summary judgment in favor of the U.S. Chamber of Commerce and Texas Association of Business, holding that the Internal Revenue...more

Proposed Regulations Would Fundamentally Change Treatment of Intra-Group Debt Transactions

BakerHostetler on 4/8/2016

On April 4, 2016, the U.S. Department of the Treasury and Internal Revenue Service (IRS) issued two sets of regulations, temporary regulations addressing “inversion” transactions and proposed regulations regarding the...more

New Temporary Inversion Regulations

Lowndes on 4/7/2016

The IRS once again is targeting inversions, and this time there have been immediate tangible results. The IRS issued temporary regulations on Monday targeting inversion transactions. An inversion occurs where a foreign...more

Private Equity's Inversion Excursion: Pepper Hamilton Talks Tax With the Deal

Troutman Pepper on 8/20/2014

In this interview with The Deal’s Jon Marino, Pepper Hamilton LLP's Joan Arnold, a partner who heads the firm's tax group, says Pfizer’s play for AstraZeneca isn’t the only inversion deal being sought. There are no shortages...more

Anti-Inversion Legislation May Impact Non-Inverted Private Equity Deals

Troutman Pepper on 7/25/2014

Corporate inversions have been the target of regulatory or statutory tax proposals for many years. However, the recently attempted combination of Pfizer and AstraZeneca received prompt and more far-reaching attention in the...more

As Congress Seeks Additional Funding, Inversion Proposal Emerges

Brownstein Hyatt Farber Schreck on 6/6/2014

Throughout the past several weeks, Pfizer’s attempt to acquire AstraZeneca has garnered significant congressional and media attention. Pfizer, a U.S. multinational corporation, made a bid for AstraZeneca in an effort to move...more